AORT News and Press, Artivion Inc Com

Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference PR Newswire ATLANTA , March 3, 2026 /PRNewswire/ --  Artivion, Inc. (NYSE...

2026-02-12 23:05:45 ET More on Artivion Artivion, Inc. (AORT) Q4 2025 Earnings Call Transcript Artivion Continues Building Toward Bigger And Better Things Seeking Alpha’s Quant Rating on Artivion Historical earnings data for Artivion Financial ...

2026-02-12 23:04:19 ET Artivion, Inc. (AORT) Q4 2025 Earnings Call February 12, 2026 4:30 PM EST Company Participants James Mackin - Chairman, President & CEO Lance Berry - EVP, COO, CFO & Treasurer Conference Call Participants Dorothy Morgan - ...

2026-02-12 18:55:15 ET Image source: The Motley Fool. Thursday, Feb. 12, 2026 at 4:30 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-02-12 16:13:34 ET More on Artivion Artivion Continues Building Toward Bigger And Better Things Seeking Alpha’s Quant Rating on Artivion Historical earnings data for Artivion Financial information for Artivion Read the full article on See...

Artivion Reports Fourth Quarter and Full Year 2025 Financial Results PR Newswire Fourth Quarter Highlights: GAAP revenue was $116.0 million in the fourth quarter of 2025 versus $97.3 million in the fourth quarter of 2024. For the full year, GAAP revenue was $441.3 million versu...

Baxter International Inc. (BAX) is expected to report $0.53 for Q4 2025 Nova Ltd. (NVMI) is expected to report $1.94 for Q4 2025 West Pharmaceutical Services Inc. (WST) is expected to report $1.83 for Q4 2025 Universal Logistics Holdings Inc. (ULH) is expected to report $-0.05 for Q4 ...

2026-02-03 10:31:10 ET The Liberty All-Star Growth Fund ( ASG ) is a closed-end equity fund that investors in search of income may wish to purchase as a means of generating a high level of current income without the need to sacrifice their equity exposure.... Read the full art...

Artivion Announces Presentation of Positive New Clinical Data from NEXUS TRIOMPHE and AMDS PERSEVERE Trials at the 62nd Society of Thoracic Surgery Annual Meeting PR Newswire 1-Year Data from Endospan's NEXUS TRIOMPHE IDE Trial Demonstrate High Patient Survival with Low Morbidity ...

Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter 2025 Financial Results PR Newswire ATLANTA , Jan. 29, 2026 /PRNewswire/ --  Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announce...